Assessment of Studies Evaluating Incremental Costs, Effectiveness, or Cost-Effectiveness of Systemic Therapies in Breast Cancer Based on Claims Data: A Systematic Review.

Luyendijk, Marianne; Vernooij, Robin W M; Blommestein, Hedwig M; Siesling, Sabine; Uyl-de Groot, Carin A

Luyendijk, Marianne; Vernooij, Robin W M; Blommestein, Hedwig M; Siesling, Sabine; Uyl-de Groot, Carin A.

Affiliation

Luyendijk M; Department of Research and Development, Netherlands Comprehensive Cancer Center, Utrecht, The Netherlands; Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands. Electronic address: M.luyendijk@iknl.nl.
Vernooij RWM; Department of Research and Development, Netherlands Comprehensive Cancer Center, Utrecht, The Netherlands.
Blommestein HM; Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands.
Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Center, Utrecht, The Netherlands; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
Uyl-de Groot CA; Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands.

Value Health ; 23(11): 1497-1508, 2020 11.

Article in En | MEDLINE | ID: mdl-33127021

Subject(s)
Key words

administrative data; claims data; secondary data

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Survival / Insurance Claim Review / Breast Neoplasms / Cost-Benefit Analysis Type of study: Guideline / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limits: Female / Humans Country/Region as subject: America do norte / Asia Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2020 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google